Author

Kinnari Sathe

Observed name: K. Sathe

Observed institution: University of Aberdeen

OpenAlex ID: A5087392813

S100B is increased in Parkinson’s disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway

2012 · Kinnari Sathe, Walter Maetzler, et al. · Brain · 202

Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity

2012 · Peter Teismann, Kinnari Sathe, et al. · Neurobiology of Aging · 75

Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease

2012 · Heather L. Martin, Ross B. Mounsey, et al. · Experimental Neurology · 68

A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s disease

2013 · H.L. Martin, R.B. Mounsey, et al. · Neuroscience · 47

HMGB-1: an inflammatory mediator in MPTP induced neuronal damage

2010 · Kinnari Sathe, Sarah Mustafa, et al. · 1

The deleterious effects of High Mobility Group Box 1 in the MPTP model and Parkinson's disease can be attenuated by glycyrrhizin

2014 · Peter Teismann, Kinnari Sathe, et al.

The RAGE ligands HMGB1 and S100B as biomarkers and targets in Parkinson’s disease

2014 · Peter Teismann, Kinnari Sathe, et al.

MHCII ablation attenuates reactive gliosis and alters cytokine responses in the MPTP-model of Parkinson’s disease

2013 · Peter Teismann, Heather L. Martin, et al.

Pharmacological and genetic manipulation of peroxisome proliferator-activated receptors in the MPTP model of Parkinson’s disease

2013 · Ross B. Mounsey, Heather L. Martin, et al.

MHCII and the innate immune system: what is their role in Parkinson's disease?

2011 · Peter Teismann, Heather Martin, et al. · Social Neuroscience

Pharmacological manipulation of peroxisome proliferator activated receptor γ reveals a role for anti-oxidant protection in a model of Parkinson’s disease

2010 · Heather L. Martin, Kinnari Sathe, et al.

Ablation of major histocompatibility complex II provides neuroprotection in the MPTP mouse model of Parkinson’s Disease

2010 · Heather L. Martin, Kinnari Sathe, et al.

Inhibition of the prostaglandin E2 receptor subtype P1 provides neuroprotection in the MPTP-model of Parkinson’s disease

2010 · Sarah Mustafa, Ross B. Mounsey, et al.

The role of inflammatory mediators S100B, HMGB1 and TWEAK in MPTP induced neurotoxicity

2010 · Kinnari Sathe · OpenGrey (Institut de l'Information Scientifique et Technique)

Prostglandin E2 receptor subtypes 1 (EP1) and 2 (EP2) receptors are implicated in dopaminergic neurodegeneration

2009 · Sarah Mustafa, Ya‐Ching Hsieh, et al.

A protective role of Peroxisome proliferator-activated receptor-γ in the MPTP mouse model of Parkinson’s Disease?

2009 · Heather L. Martin, Kinnari Sathe, et al.

The role of peroxisome-proliferator activated receptors in a model of Parkinson’s disease

2008 · Heather L. Martin, Kinnari Sathe, et al.

S100B - a mediator of cell death in the MPTP-mouse model of Parkinson's disease

2008 · Kinnari Sathe, Heather L. Martin, et al.

Works count: 18

Citation count: 393

H-index: 4

I10-index: 4